These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22190199)

  • 1. Assay of in vitro osteoclast activity on dentine, and synthetic calcium phosphate bone substitutes.
    Badran Z; Pilet P; Verron E; Bouler JM; Weiss P; Grimandi G; Guicheux J; Soueidan A
    J Mater Sci Mater Med; 2012 Mar; 23(3):797-803. PubMed ID: 22190199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar healthy osteoclast and osteoblast activity on nanocrystalline hydroxyapatite and nanoparticles of tri-calcium phosphate compared to natural bone.
    MacMillan AK; Lamberti FV; Moulton JN; Geilich BM; Webster TJ
    Int J Nanomedicine; 2014; 9():5627-37. PubMed ID: 25506216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of RANKL promotes osteoclast formation and osteoclast activity on β-TCP ceramics.
    Choy J; Albers CE; Siebenrock KA; Dolder S; Hofstetter W; Klenke FM
    Bone; 2014 Dec; 69():80-8. PubMed ID: 25245204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoclastic differentiation and resorption is modulated by bioactive metal ions Co2+, Cu2+ and Cr3+ incorporated into calcium phosphate bone cements.
    Bernhardt A; Schamel M; Gbureck U; Gelinsky M
    PLoS One; 2017; 12(8):e0182109. PubMed ID: 28763481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bovine dentine organic matrix down-regulates osteoclast activity.
    Sriarj W; Aoki K; Ohya K; Takagi Y; Shimokawa H
    J Bone Miner Metab; 2009; 27(3):315-23. PubMed ID: 19296049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoclastogenesis and osteoclastic resorption of tricalcium phosphate: effect of strontium and magnesium doping.
    Roy M; Bose S
    J Biomed Mater Res A; 2012 Sep; 100(9):2450-61. PubMed ID: 22566212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volumetric analysis of osteoclastic bioresorption of calcium phosphate ceramics with different solubilities.
    Winkler T; Hoenig E; Gildenhaar R; Berger G; Fritsch D; Janssen R; Morlock MM; Schilling AF
    Acta Biomater; 2010 Oct; 6(10):4127-35. PubMed ID: 20451677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro osteoclast resorption of bone substitute biomaterials used for implant site augmentation: a pilot study.
    Taylor JC; Cuff SE; Leger JP; Morra A; Anderson GI
    Int J Oral Maxillofac Implants; 2002; 17(3):321-30. PubMed ID: 12074446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of osteoclast-like cells on HA and TCP ceramics.
    Detsch R; Mayr H; Ziegler G
    Acta Biomater; 2008 Jan; 4(1):139-48. PubMed ID: 17723325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro: osteoclastic activity studies on surfaces of 3D printed calcium phosphate scaffolds.
    Detsch R; Schaefer S; Deisinger U; Ziegler G; Seitz H; Leukers B
    J Biomater Appl; 2011 Sep; 26(3):359-80. PubMed ID: 20659962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoclast resorption of beta-tricalcium phosphate controlled by surface architecture.
    Davison NL; ten Harkel B; Schoenmaker T; Luo X; Yuan H; Everts V; Barrère-de Groot F; de Bruijn JD
    Biomaterials; 2014 Aug; 35(26):7441-51. PubMed ID: 24927681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent resorbability and effects on osteoclast formation of commonly used bone substitutes in a human in vitro-assay.
    Keller J; Brink S; Busse B; Schilling AF; Schinke T; Amling M; Lange T
    PLoS One; 2012; 7(10):e46757. PubMed ID: 23071629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of osteoclast-specific enzyme activities in cell-based in vitro resorption assays.
    Bernhardt A; Koperski K; Schumacher M; Gelinsky M
    Eur Cell Mater; 2017 Jan; 33():28-42. PubMed ID: 28098926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoclastic resorption of biomimetic calcium phosphate coatings in vitro.
    Leeuwenburgh S; Layrolle P; Barrère F; de Bruijn J; Schoonman J; van Blitterswijk CA; de Groot K
    J Biomed Mater Res; 2001 Aug; 56(2):208-15. PubMed ID: 11340590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local delivery of iron chelators reduces in vivo remodeling of a calcium phosphate bone graft substitute.
    Drager J; Sheikh Z; Zhang YL; Harvey EJ; Barralet JE
    Acta Biomater; 2016 Sep; 42():411-419. PubMed ID: 27449336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells.
    Coxon FP; Thompson K; Roelofs AJ; Ebetino FH; Rogers MJ
    Bone; 2008 May; 42(5):848-60. PubMed ID: 18325866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoclast-like cells on deproteinized bovine bone mineral and biphasic calcium phosphate: light and transmission electron microscopical observations.
    Jensen SS; Gruber R; Buser D; Bosshardt DD
    Clin Oral Implants Res; 2015 Aug; 26(8):859-864. PubMed ID: 24665833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoclastic bioresorption of biomaterials: two- and three-dimensional imaging and quantification.
    Winkler T; Hoenig E; Huber G; Janssen R; Fritsch D; Gildenhaar R; Berger G; Morlock MM; Schilling AF
    Int J Artif Organs; 2010 Apr; 33(4):198-203. PubMed ID: 20458689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitors control osteoclastic resorption of calcium phosphate implants and stimulate increased local reparative bone growth.
    Rzeszutek K; Sarraf F; Davies JE
    J Craniofac Surg; 2003 May; 14(3):301-7. PubMed ID: 12826800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of gastrointestinal proton pump inhibitors to regulate osteoclast-mediated resorption of calcium phosphate cements in vivo.
    Sheraly AR; Lickorish D; Sarraf F; Davies JE
    Curr Drug Deliv; 2009 Apr; 6(2):192-8. PubMed ID: 19450226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.